Answers are grounded in this paper and cite their sources.
A novel vaccine adjuvant based on a supramolecular hydrogel of a D-tetra-peptide is reported. Antigens can be easily incorporated into the hydrogel by a vortex or by gently shaking before injection. The vaccines can stimulate strong CD8+ T-cell responses, which significantly inhibits tumor growth. This novel adjuvant is expected to enable a wide range of sub-unit vaccines and help the production of antibodies.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: